Biosimilars (ne)jen v onkologii –⁠ dnešní realita i budoucnost

Czech version

Authors: R. Demlová ^1,2
Authors‘ workplace: Oddělení klinických hodnocení, Masarykův onkologický ústav, Brno ¹; Farmakologický ústav LF MU, Brno ²
Published in: Klin Onkol 2014; 27(1): 64-66
Category: Oncology Highlights

Overview

Submitted:
12. 12. 2013

Sources

1. Kresse GB. Biosimilars –⁠ science, status, and strategic perspective. Eur J Pharm Biopharm 2009; 72(3): 479–486. doi: 10.1016/j.ejpb.2009.02.014.

2. Egagenerics.com [homepage on the internet]. European Genetic Medicines Association. c2004–2012 EGA. Available from: www.egagenerics.com.

3. Ema.europa.eu [homepage on the internet]. European Medicines Agency. United Kingdom c1995–2014 EMA. Available from: www.ema.europa.eu.

4. Krämer I. Pharmacy and pharmacology of biosimilars. J Endocrinol Invest 2008, 31(5): 479–488.

5. Zuñiga L, Calvo B. Biosimilars approval process. Regul Toxicol Pharmacol 2010; 56(3): 374–377.

Labels

Paediatric clinical oncology Surgery Clinical oncology

Cytokine Profiles of Multiple Myeloma and Waldenström Macroglobulinemia

Double‑hit Lymphomas – Review of the Literature and Case Report

Interaction between p53 and MDM2 in Human Lung Cancer Cells

Surgical Treatment of Metastases and its Impact on Prognosis in Patients with Metastatic Colorectal Carcinoma

MRI Based 3D Brachytherapy Planning of the Cervical Cancer – Our Experiences with the Use of the Uterovaginal Vienna Ring MR‑ CT Applicator

Second Primary Cancers – Causes, Incidence and the Future

Zajímavé případy z nutriční péče v onkologii

Enzalutamid (Xtandi®) – nová šance pro pacienty s kastračně refrakterním karcinomem prostaty

Onkologie v obrazech Umělecké projevy toxicity protinádorové léčby

Significant Anti‑tumor Effectiveness of Imatinib in C‑ kit Negative Gastrointestinal Stromal Tumor – Case Report

Gastric Gastrointestinal Stromal Tumor with Bone Metastases – Case Report and Review of the Literature

Knowledge Transfer at the RECAMO Summer School of 2013

Article was published in

Clinical Oncology

2014 Issue 1